SODIUM BICARBONATE injection, solution United States - English - NLM (National Library of Medicine)

sodium bicarbonate injection, solution

us medsource, llc - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection, usp is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments. sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis ― e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. but since an appreciable time interval may elapse before

PHYSIONEAL 40 Glucose 2.27% w/v Peritoneal Dialysis Solution Bag Australia - English - Department of Health (Therapeutic Goods Administration)

physioneal 40 glucose 2.27% w/v peritoneal dialysis solution bag

vantive pty ltd - sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; glucose monohydrate, quantity: 25 g/l (equivalent: glucose, qty 22.7 g/l); calcium chloride dihydrate, quantity: 0.184 g/l; sodium chloride, quantity: 5.38 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

DIANEAL PD-4 Peritoneal Dialysis Solution with    0.55% w/v Glucose Low Calcium Standard Single Bag Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal pd-4 peritoneal dialysis solution with 0.55% w/v glucose low calcium standard single bag

vantive pty ltd - sodium chloride, quantity: 5.38 g/l; calcium chloride dihydrate, quantity: 0.183 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; sodium lactate, quantity: 4.48 g/l; glucose monohydrate, quantity: 5.5 g/l - solution, irrigation - excipient ingredients: sodium hydroxide; water for injections - use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

DIANEAL PD-4 Peritoneal Dialysis Solution with    0.55% w/v Glucose Low Calcium Freeline Solo Twin Australia - English - Department of Health (Therapeutic Goods Administration)

dianeal pd-4 peritoneal dialysis solution with 0.55% w/v glucose low calcium freeline solo twin

vantive pty ltd - sodium chloride, quantity: 5.39 g/l; calcium chloride dihydrate, quantity: 0.183 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; sodium lactate, quantity: 4.48 g/l; glucose monohydrate, quantity: 5.5 g/l - solution, dialysis - excipient ingredients: sodium hydroxide; water for injections - indications: use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

CAPD/DPCA 19 sleep safe peritoneal dialysis solution bag Australia - English - Department of Health (Therapeutic Goods Administration)

capd/dpca 19 sleep safe peritoneal dialysis solution bag

fresenius medical care australia pty ltd - sodium chloride, quantity: 5.786 g/l; chloride, quantity: 102.5 mmol/l; calcium chloride dihydrate, quantity: 0.1838 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; magnesium, quantity: 0.5 mmol/l; lactate, quantity: 35 mmol/l; sodium lactate, quantity: 3.925 g/l; glucose monohydrate, quantity: 25 g/l; calcium, quantity: 1.25 mmol/l; sodium, quantity: 134 mmol/l - solution, irrigation - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Volulyte 6% solution for infusion Malta - English - Medicines Authority

volulyte 6% solution for infusion

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - poly, hydroxyethyl, starch, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium chloride - solution for infusion - sodium acetate trihydrate 4.63 g sodium chloride 6.02 g magnesium chloride hexahydrate 0.3 g poly(o-2-hydroxyethyl)starch 60 g potassium chloride 0.3 g - blood substitutes and perfusion solutions

SMOFKABIVEN NTENSE amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2531 mL  bag Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2531 ml bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

SMOFKABIVEN NTENSE amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2025 mL bag Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2025 ml bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

SMOFKABIVEN NTENSE amino acid 6.5% with 0.7% electrolytes,  lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 1518 mL bag Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 1518 ml bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

SMOFKABIVEN NTENSE amino acid 6.5% with 0.7% electrolytes,  lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 1012 mL bag Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 1012 ml bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated